This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Pharmacologic Approaches to the Management of Alcoholism

Raymond F. Anton, MD

Published: January 6, 2001

Article Abstract

Our understanding of alcohol craving, both as a cause for chronic abuse and relapse and as a targetfor intervention, has been refined significantly in recent years. For example, craving experienced duringalcohol withdrawal may be mediated by γ-aminobutyric acid (GABA) and glutamate receptormechanisms, whereas the memory of the rewarding aspects of alcohol may be mediated by dopamine,opiate, and glutamate systems. Therefore, pharmacologic treatments for alcohol dependence may betargeted to numerous pathways. This article will discuss animal and clinical studies of the opioid antagonists(primarily naltrexone), acamprosate, and disulfiram. The side effects and treatment recommendationsfor each drug will also be reviewed.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 62

Quick Links: Addiction , Substance Use Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...